Treace Medical Concepts I... (TMCI)
Treace Medical Concepts Statistics
Share Statistics
Treace Medical Concepts has 62.62M shares outstanding. The number of shares has increased by 0.88% in one year.
| Shares Outstanding | 62.62M |
| Shares Change (YoY) | 0.88% |
| Shares Change (QoQ) | 0.17% |
| Owned by Institutions (%) | 63.04% |
| Shares Floating | 44.91M |
| Failed to Deliver (FTD) Shares | 288 |
| FTD / Avg. Volume | 0.08% |
Short Selling Information
The latest short interest is 2.27M, so 3.64% of the outstanding shares have been sold short.
| Short Interest | 2.27M |
| Short % of Shares Out | 3.64% |
| Short % of Float | 5% |
| Short Ratio (days to cover) | 7.98 |
Valuation Ratios
The PE ratio is -8.29 and the forward PE ratio is -13.53. Treace Medical Concepts's PEG ratio is -0.75.
| PE Ratio | -8.29 |
| Forward PE | -13.53 |
| PS Ratio | 2.21 |
| Forward PS | 1.7 |
| PB Ratio | 4.09 |
| P/FCF Ratio | -9.48 |
| PEG Ratio | -0.75 |
Enterprise Valuation
Treace Medical Concepts Inc. has an Enterprise Value (EV) of 833.19M.
| EV / Earnings | -14.95 |
| EV / Sales | 3.98 |
| EV / EBITDA | -19.81 |
| EV / EBIT | -14.96 |
| EV / FCF | -17.09 |
Financial Position
The company has a current ratio of 4.62, with a Debt / Equity ratio of 0.62.
| Current Ratio | 4.62 |
| Quick Ratio | 3.5 |
| Debt / Equity | 0.62 |
| Total Debt / Capitalization | 38.16 |
| Cash Flow / Debt | -0.53 |
| Interest Coverage | -10.6 |
Financial Efficiency
Return on equity (ROE) is -0.49% and return on capital (ROIC) is -30.51%.
| Return on Equity (ROE) | -0.49% |
| Return on Assets (ROA) | -0.26% |
| Return on Capital (ROIC) | -30.51% |
| Revenue Per Employee | $438,903.56 |
| Profits Per Employee | $-116,861.64 |
| Employee Count | 477 |
| Asset Turnover | 0.96 |
| Inventory Turnover | 1.05 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -36.61% in the last 52 weeks. The beta is 0.78, so Treace Medical Concepts's price volatility has been higher than the market average.
| Beta | 0.78 |
| 52-Week Price Change | -36.61% |
| 50-Day Moving Average | 8.84 |
| 200-Day Moving Average | 6.97 |
| Relative Strength Index (RSI) | 39.14 |
| Average Volume (20 Days) | 364.12K |
Income Statement
In the last 12 months, Treace Medical Concepts had revenue of 209.36M and earned -55.74M in profits. Earnings per share was -0.9.
| Revenue | 209.36M |
| Gross Profit | 168.26M |
| Operating Income | -55.69M |
| Net Income | -55.74M |
| EBITDA | -42.07M |
| EBIT | -55.69M |
| Earnings Per Share (EPS) | -0.9 |
Balance Sheet
The company has 11.35M in cash and 69.65M in debt, giving a net cash position of -58.3M.
| Cash & Cash Equivalents | 11.35M |
| Total Debt | 69.65M |
| Net Cash | -58.3M |
| Retained Earnings | -189.99M |
| Total Assets | 212.92M |
| Working Capital | 119.34M |
Cash Flow
In the last 12 months, operating cash flow was -37.17M and capital expenditures -11.59M, giving a free cash flow of -48.76M.
| Operating Cash Flow | -37.17M |
| Capital Expenditures | -11.59M |
| Free Cash Flow | -48.76M |
| FCF Per Share | -0.79 |
Margins
Gross margin is 80.37%, with operating and profit margins of -26.6% and -26.63%.
| Gross Margin | 80.37% |
| Operating Margin | -26.6% |
| Pretax Margin | -26.63% |
| Profit Margin | -26.63% |
| EBITDA Margin | -20.09% |
| EBIT Margin | -26.6% |
| FCF Margin | -23.29% |
Dividends & Yields
TMCI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -10.33% |
| FCF Yield | -8.95% |
Analyst Forecast
The average price target for TMCI is $8, which is -8.2% lower than the current price. The consensus rating is "Hold".
| Price Target | $8 |
| Price Target Difference | -8.2% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
Scores
| Altman Z-Score | 2.86 |
| Piotroski F-Score | 2 |